About Prognosis
Prognosis is a company based in Delhi (India) founded in 2002 by Deepak Sadwani and Smita Sadwani was acquired by MedGenome in May 2023. The company has 74 employees as of November 30, 2024.
- Headquarter Delhi, India
- Employees 74 as on 30 Nov, 2024
- Founders Deepak Sadwani, Smita Sadwani
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Prognosis Laboratories
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Prognosis
Detailed funding history for Prognosis
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Prognosis
Prognosis has secured backing from 1 investor. Prominent investors backing the company include MedGenome.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
DNA sequencing, bioinformatics, and multiomics services are provided.
|
Locked | Locked | Locked |
Investor details for Prognosis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Prognosis
Investment portfolio details for Prognosis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Prognosis
Detailed financials for Prognosis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Prognosis Comparisons
Peer comparison for Prognosis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Prognosis
Detailed competitors of Prognosis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Prognosis
Complete news archive for Prognosis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Prognosis
Prognosis was founded in 2002.
Prognosis is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
As of Nov 30, 2024, the latest employee count at Prognosis is 74.
Annual revenue of Prognosis is $1.72M as on Mar 31, 2024.
Prognosis was established in 2002 as a standalone diagnostic centre in Delhi, India. Operations focus on healthcare diagnostics within the medical sector. A range of services is provided, encompassing cardiology consultations, radiology examinations, pathology testing, and imaging modalities such as digital X-ray and ultrasonography. The centre is directed by co-founders Deepak Sadwani and Smita Sadwani.
Prognosis has 1 investor. Key investors include MedGenome.